As expected, serum galectin-3 levels were significantly higher in HD patients compared to healthy controls (35.8 ± 15.9 vs. 7.2 ± 2.9 ng/mL, p < 0.001) (Fig. 1A). This evidence concerns the gene LGALS3 and Huntington disease.